Supplemental material
Emerging Microbes & Infections
Volume 8, 2019 - Issue 1
Letter
Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
Florine E. M. Scholtea Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA
https://orcid.org/0000-0003-2110-3087View further author information
https://orcid.org/0000-0003-2110-3087View further author information, Jessica R. Spenglera Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USAhttps://orcid.org/0000-0002-5383-0513View further author information
https://orcid.org/0000-0002-5383-0513View further author information, Stephen R. Welcha Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USAhttps://orcid.org/0000-0002-6905-8521View further author information
https://orcid.org/0000-0002-6905-8521View further author information, , , Brendan T. Freitasb Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, USAhttps://orcid.org/0000-0001-5847-5904View further author information
https://orcid.org/0000-0001-5847-5904View further author information, , Scott D. Peganb Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, USAhttps://orcid.org/0000-0002-2958-5319View further author information
https://orcid.org/0000-0002-2958-5319View further author information, , Éric Bergerona Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USACorrespondence[email protected]
https://orcid.org/0000-0003-3398-8628View further author information
https://orcid.org/0000-0003-3398-8628View further author information & Christina F. Spiropouloua Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USAhttps://orcid.org/0000-0001-8406-3161View further author information
https://orcid.org/0000-0001-8406-3161View further author information show allRelated Research Data
Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses
Source:
Public Library of Science (PLoS)
Viremia and antibody response of small African and laboratory animals to Crimean-Congo hemorrhagic fever virus infection.
Source:
American Society of Tropical Medicine and Hygiene
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.
Source:
Rockefeller University Press
Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice.
Source:
Public Library of Science (PLoS)
Autochthonous Crimean-Congo Hemorrhagic Fever in Spain.
Source:
Massachusetts Medical Society
Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.
Source:
Public Library of Science (PLoS)
Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection.
Source:
Oxford University Press (OUP)
Linking provided by
